Flexion Therapeutics (United States)
- Research works
- 21 ▲ 207% vs 2013–17
- Citations
- 267 13.0 per fractional work
- Top-10% rate
- 18.9% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Flexion Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Flexion Therapeutics (United States)?
Ranked on the composite score, Scott D. Kelley lead among researchers whose main affiliation is Flexion Therapeutics (United States).
- 1 Scott D. Kelley United States · #1,364,823 worldwide 9 citations · 19 works
Which keywords describe research at Flexion Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Regeneration, Osteoarthritis, Cartilage, Chondrocyte, Cardiovascular Risk, Cyclooxygenase-2 Inhibitors and Rheumatoid Arthritis.
- Freeform Optics
- Compound Eyes
- Pain Management
- Rheumatoid Arthritis
- Cyclooxygenase-2 Inhibitors
- Cardiovascular Risk
- Cartilage
- Regeneration
- Inflammation
- Osteoarthritis
- Chondrocyte
- Cancer
- Epidemiology
- Chronic Pain
- Biological Therapy
- Disease-Modifying Antirheumatic Drugs
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Inflammation8▲ 17×5 topics
- Regeneration6▲ 171×2 topics
- Osteoarthritis6▲ 225×2 topics
- Cartilage6▲ 597×1 topic
- Chondrocyte6▲ 597×1 topic
- Cardiovascular Risk3▲ 37×3 topics
- Cancer2▲ 5.2×1 topic
- Cyclooxygenase-2 Inhibitors2▲ 188×1 topic
- Epidemiology2▲ 1.76×7 topics
- Rheumatoid Arthritis1▲ 64×2 topics
- Chronic Pain1▲ 24×3 topics
- Pain Management1▲ 22×4 topics
- Biological Therapy1▲ 88×1 topic
- Compound Eyes1▲ 358×1 topic
- Disease-Modifying Antirheumatic Drugs1▲ 101×1 topic
- Freeform Optics1▲ 358×1 topic
Which research topics does Flexion Therapeutics (United States) publish most on?
By volume in 2022–2025: Musculoskeletal pain and rehabilitation, Spine and Intervertebral Disc Pathology, Shoulder Injury and Treatment and Plant Toxicity and Pharmacological Properties.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Musculoskeletal pain and rehabilitation Pharmacology 0 works
- 2 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
- 3 Shoulder Injury and Treatment Surgery 0 works
- 4 Plant Toxicity and Pharmacological Properties Molecular Biology 0 works
- 5 Orthopedic Surgery and Rehabilitation Surgery 0 works
- 6 Immunotherapy and Immune Responses Immunology 0 works
- 7 HIV Research and Treatment Virology 0 works
- 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 9 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
- 10 Shoulder and Clavicle Injuries Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Flexion Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 207% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Burlington
- Lahey Hospital and Medical Center
- Spectral Sciences (United States)
- Arqule (United States)
- Nuance Communications (United States)
- UFA (United States)
- Visidyne (United States)
- Boston Fusion (United States)
- Marine Polymer Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.